Insider · SEC Form 4 filer
James Healy
Past buys: 1 of 3 beat
Companies
Where they file as an insider
Rapport Therapeutics (RAPP) Director Latest filing Oct 28, 2026
Seaport Therapeutics (SPTX) Director Latest filing May 4, 2026
Y-mAbs Therapeutics (YMAB) Director Latest filing Sep 16, 2025
Natera (NTRA) Director Latest filing Apr 25, 2025
BioAge Labs (BIOA) Director Latest filing Sep 27, 2024
Karuna Therapeutics (KRTX) Director Latest filing Mar 18, 2024
ArriVent Biopharma (AVBP) Director Latest filing Jan 30, 2024
Track record
Did their buys beat the typical stock?
Open-market buys27
Quarters checked 6 months later3
Beat the typical stock 1 of 3
Quarters too new to check1
1 of 3 checked quarters beat the typical stock. A past record is data, not a forecast.
Rapport Therapeutics (RAPP) Bought Oct 28, 2026 · $20.4M · 969,480 shares Too new Too new. Its 6-month check uses prices as of Jun 30, 2027.
BioAge Labs (BIOA) Bought Sep 27, 2024 · $12M · 666,665 shares Not counted Not counted. We have no fund price for this stock on both Sep 30, 2024 and Mar 31, 2025.
Rapport Therapeutics (RAPP) Bought Jul 1, 2024 · $1.08M · 44,032 shares Behind typical Sep 30, 2024 $20.48 → Mar 31, 2025 $10.03 · −51.0% (typical stock −7.5%)
Rapport Therapeutics (RAPP) Bought Jun 10, 2024 · $9.5M · 558,824 shares Behind typical Jun 30, 2024 $23.26 → Dec 31, 2024 $17.74 · −23.7% (typical stock +3.9%)
ArriVent Biopharma (AVBP) Bought Jan 30, 2024 · $8M · 444,444 shares Beat typical Mar 31, 2024 $17.86 → Sep 30, 2024 $23.50 · +31.6% (typical stock +3.2%)
Each row is one stock in one quarter, however many buys it took. We take the stock's price at the end of that quarter and again 6 months later, and compare it with the typical stock over the same dates. Prices are quarter-end values from funds' 13F reports (the middle value across 3 or more funds), through Sep 30, 2026. Moves past 3 times up or down, mostly stock splits, are left out. How we tested this.
Past results. This is data, not advice.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.